mibefradil has been researched along with Cirrhosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clozel, JP; Clozel, M; Gonzales, MF; Hess, P; Heudes, D; Karam, H; Löffler, BM | 1 |
Bruneval, P; Clozel, JP; Clozel, M; Gonzales, MF; Heudes, D; Karam, H; Löffler, BM | 1 |
Ramires, FJ; Sun, Y; Weber, KT | 1 |
Bohle, RM; Dreyer, T; Sandmann, S; Unger, T | 1 |
4 other study(ies) available for mibefradil and Cirrhosis
Article | Year |
---|---|
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Bosentan; Calcium Channel Blockers; Cardiomegaly; Collagen; Coronary Circulation; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Fibrosis; Hypertension; Male; Mibefradil; Myocardium; Perfusion; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes | 1996 |
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Benzimidazoles; Body Weight; Bosentan; Calcium Channel Blockers; Cardiomegaly; Coronary Circulation; Enalapril; Endothelins; Fibrosis; Heart Ventricles; Hemodynamics; Hormones; Hypertension; Kidney; Mibefradil; Myocardium; Rats; Rats, Inbred SHR; Sulfonamides; Tetrahydronaphthalenes | 1996 |
Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
Topics: Aldosterone; Angiotensin II; Animals; Benzimidazoles; Calcium; Calcium Channel Blockers; Collagen; Drug Interactions; Fibroblasts; Fibrosis; Heart; Hydroxyproline; Intracellular Fluid; Male; Mibefradil; Myocardium; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Tetrahydronaphthalenes | 1998 |
The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Fibrosis; Heart; Heart Failure; Hemodynamics; Male; Mibefradil; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Ventricular Remodeling | 2000 |